Biallelic NEXN variants and fetal onset dilated cardiomyopathy: two independent case reports and revision of literature
-
Published:2024-08-26
Issue:1
Volume:50
Page:
-
ISSN:1824-7288
-
Container-title:Italian Journal of Pediatrics
-
language:en
-
Short-container-title:Ital J Pediatr
Author:
Picciolli IreneORCID, Ratti Angelo, Rinaldi Berardo, Baban Anwar, Iascone Maria, Francescato Gaia, Cappelleri Alessia, Magliozzi Monia, Novelli Antonio, Parlapiano Giovanni, Colli Anna Maria, Persico Nicola, Carugo Stefano, Mosca Fabio, Bedeschi Maria Francesca
Abstract
Abstract
Background
Dilated cardiomyopathy (DCM) is an etiologically heterogeneous group of diseases of the myocardium. With the rapid evolution in laboratory investigations, genetic background is increasingly determined including many genes with variable penetrance and expressivity. Biallelic NEXN variants are rare in humans and associated with poor prognosis: fetal and perinatal death or severe DCMs in infants.
Case presentation
We describe two male infants with prenatal diagnosis of dilated cardiomyopathy with impaired ventricular contractility. One of the patients showed hydrops and polyhydramnios. Postnatally, a DCM with severely reduced systolic function was confirmed and required medical treatment. In patient 1, Whole Exome Sequencing (WES) revealed a homozygous NEXN variant: c.1156dup (p.Met386fs) while in patient 2 a custom Next Generation Sequencing (NGS) panel revealed the homozygous NEXN variant c.1579_1584delp. (Glu527_Glu528del). These NEXN variants have not been previously described. Unlike the unfavorable prognosis described for biallelic NEXN variants, we observed in both our patients a favorable clinical course over time.
Conclusion
This report might help to broaden the present knowledge regarding NEXN biallelic variants and their clinical expression. It might be worthy to consider the inclusion of the NEXN gene sequencing in the investigation of pediatric patients with DCM.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Seferović PM, Polovina M, Bauersachs J, Arad M, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:553–76. 2. Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD, Hsu DT, Lin KY, Price JF, Wilkinson JD, Colan SD. Cardiomyopathy in children: classification and diagnosis: a Scientific Statement from the American Heart Association. Circulation. 2019;140(1):e9–68. 3. Lodato V, Parlapiano G, Calì F, Silvetti MS, Adorisio R, Armando M, El Hachem M, Romanzo A, Dionisi-Vici C, Digilio MC, Novelli A, Drago F, Raponi M, Baban A. Cardiomyopathies in children and systemic disorders when is it useful to look beyond the heart? J Cardiovasc Dev Dis. 2022;9(2):47. 4. Haas J, Frese KS, Peil B, Kloos W, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J. 2015;36(28):1123–a35. 5. Hassel D, Dahme T, Erdmann J, Meder B, Huge A, Stoll M, Just S, Hess A, Ehlermann P, Weichenhan D, Grimmler M, Liptau H, Hetzer R, Regitz-Zagrosek V, Fisher C, Nürnberg P, Schunkert H, Katus HA, Rottbauer W. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med. 2009;15(11):1281–8.
|
|